Drug Detail

Drug Name Cisplatin
Trade Name Platinol
Synonyms CDDP
Drug Descriptions

Platinol (cisplatin) is a platinum based chemotherapeutic, which is FDA approved for bladder, ovarian, and testicular cancers (NCI Drug Dictionary).

DrugClasses Chemotherapy - Platinum 6

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Therapy Description
BAY80-6946 + Cisplatin + Gemcitabine
Cisplatin + Etoposide + Panobinostat + Radiotherapy
Carboplatin + Cisplatin + Pemetrexed
Selumetinib + Cisplatin + Gemcitabine
Crolibulin + Cisplatin
Cisplatin + Etoposide + M7824 M7824 is a human PD-L1 (CD274) antibody fused with transforming growth factor-beta (TGF-beta, TGFBR2) receptor II extracellular domain, which blocks two immuno-inhibitory pathways simultaneously, therefore enhances anti-tumor immunity (PMID: 29298798).
Carboplatin + Cisplatin + nab-paclitaxel + Pemetrexed
Gemcitabine + Bevacizumab + Cisplatin
Metformin + PEXG
Cisplatin Platinol (cisplatin) is a platinum based chemotherapeutic, which is FDA approved for bladder, ovarian, and testicular cancers (NCI Drug Dictionary).
Cisplatin + Gemcitabine + Nab-paclitaxel
Cisplatin + Docetaxel + Cetuximab
Cisplatin + Everolimus + Paclitaxel
CBP501 + Cisplatin
CEP-8983 + Cisplatin
Docetaxel + Cisplatin
Camptosar + Cisplatin
Cisplatin + Fluorouracil + Hydroxyurea
Carboplatin + Cisplatin Paraplatin (carboplatin) is a second-generation platinum compound and is activated intracellularly to form reactive platinum complexes that cross link DNA with DNA and with proteins. This induces apoptosis and inhibits cell growth (NCI Drug Dictionary).
Alpelisib + Cisplatin
Cisplatin + RRx-001
Carboplatin + Cisplatin + Gemcitabine
Anetumab ravtansine + Cisplatin + Pemetrexed
BGB-A317 + Cisplatin + Etoposide
AZD9150 + Cisplatin + Durvalumab
MK-1775 + Cisplatin
Cisplatin + JQ1
Olaparib + Cisplatin
Cisplatin + VX-970
Carboplatin + Cisplatin + Etoposide
Sorafenib + Cisplatin + Docetaxel
Cisplatin + NU6027
GSK2256098 + Cisplatin
Cisplatin + SAR405838
NANT non-small cell lung cancer vaccine
Cisplatin + Etoposide + Nivolumab
AR-42 + Cisplatin
YM155 + Cisplatin
Cisplatin + Gemcitabine + Pembrolizumab
Cisplatin + Gemcitabine + Sorafenib
Cisplatin + Fluorouracil + Pembrolizumab + Trastuzumab
Cisplatin + Veliparib + Vinorelbine
Cisplatin + Vinorelbine + Gemcitabine + Docetaxel + Pemetrexed + Carboplatin
Cisplatin + M7824 + Pemetrexed
Cisplatin + Talazoparib
Cisplatin + Etoposide + GSK3052230
PHA-680632 + Cisplatin
Cisplatin + Gemcitabine + VX-970
Cediranib + Cisplatin + Pemetrexed
BMS-986012 + Cisplatin + Etoposide
Cisplatin + Doxorubicin + Cyclophosphamide + Etoposide
Cisplatin + Dexamethasone + Gemcitabine
Carboplatin + Cisplatin + Epacadostat + Fluorouracil + Nivolumab
BMS-986205 + Cisplatin + Gemcitabine + Nivolumab
Rilotumumab + Capecitibine + Cisplatin + Epirubicin
Cisplatin + Gemcitabine + Pemigatinib
Carboplatin + Cisplatin + Epacadostat + Gemzar + Nivolumab + Taxol + Pemetrexed
MSC2490484A + Cisplatin + Etoposide
Cisplatin + Etoposide + Pembrolizumab
Cisplatin + Etoposide
Aldoxorubicin + Cisplatin + Methotrexate + Vincristine
Cisplatin + Durvalumab + Gemcitabine + Tremelimumab
Cisplatin + ETP-46464
APR-246 + Cisplatin
Avelumab + Cisplatin + Gemcitabine
AZD7762 + Cisplatin
GSK2141795 + Cisplatin
Rovalpituzumab Tesirine + Cisplatin + Etoposide
Camrelizumab + Cisplatin + Gemcitabine
Bosutinib + Cisplatin
Carboplatin + Cisplatin + Fluorouracil + Nivolumab
Cetuximab + Cisplatin + Vinorelbine
Cisplatin + Durvalumab
Cisplatin + NSC59984
Cisplatin + Custirsen + Gemcitabine
Cisplatin + TRX-E-002-1
Cisplatin + Sorafenib + Tamoxifen
Cisplatin + Paclitaxel + Bevacizumab + Olaparib
Sunitinib + Tamoxifen + Cisplatin
Lapatinib + Cisplatin
Sorafenib + Cisplatin + Paclitaxel
ADH-1 + Cisplatin + Gemcitabine
Cisplatin + Pembrolizumab + Rintatolimod Rintatolimod is a synthetic dsRNA molecule that activates TLR3 and other interferon-induced proteins, which may have anticancer effects (PMID: 27045557, PMID: 19200817).
Cisplatin + Durvalumab + Pemetrexed
Capecitabine + Fluorouracil + Cisplatin + Trastuzumab
Carboplatin + Cisplatin + Etoposide + Pembrolizumab
Cetuximab + Cisplatin + Patritumab
Alisertib + Cisplatin + Etoposide
Cisplatin + nab-paclitaxel
Cetuximab + Cisplatin + Docetaxel + Fluorouracil
Cisplatin + MLN4924 + Pemetrexed
Carboplatin + Cisplatin + Gemcitabine + Paclitaxel + Pemetrexed
MEDI5117 + Cisplatin + Gemcitabine
Cisplatin + Everolimus + Gemcitabine
Cisplatin + Fluorouracil + Trastuzumab
Cisplatin + Durvalumab + Etoposide
PF-05212384 + Cisplatin
Necitumumab + Pemetrexed + Cisplatin
Carboplatin + Cisplatin + Gemcitabine + Pemetrexed + Vinorelbine
Cisplatin + FT-2102 + Gemcitabine
Cisplatin + Gemcitabine + M7824
Cisplatin + OPB-31121
Carboplatin + Cisplatin + Denosumab + Gemcitabine
Cisplatin + Paclitaxel
Cisplatin + Doxorubicin + Fluorouracil + Vincristine
Cisplatin + Etoposide + Sonidegib
Cisplatin + VE-821
Carboplatin + Cisplatin + Docetaxel + Paclitaxel
Cisplatin + NVP-BHG712
Methotrexate + Cisplatin + Cyclophosphamide + Vincristine
Cisplatin + Nivolumab
Cisplatin + Radiotherapy
Cisplatin + DPP-23
Cisplatin + Gemcitabine + Metformin
Carboplatin + Cisplatin + Durvalumab + Pemetrexed
AZD4547 + Cisplatin + Gemcitabine
Cisplatin + Fluorouracil + Vincristine
Capecitabine + Cisplatin
Cisplatin + Cytarabine + Dexamethasone + Rituximab
Lapatinib + Carboplatin + Cisplatin + Paclitaxel
Gemcitabine + Cisplatin
Cisplatin + Durvalumab + Oleclumab
LB-100 + Cisplatin
Cisplatin + VX-803
BMX-001 + Cisplatin
Cisplatin + Doxorubicin
CBP501 + Cisplatin + Nivolumab
Cisplatin + GL-ONC1 + Radiotherapy
Bevacizumab + Cisplatin + Etoposide
Cisplatin + Dexamethasone + Gemcitabine + Rituximab
Carboplatin + Cisplatin + Gemcitabine + Nivolumab + Paclitaxel + Pemetrexed
Cisplatin + Pemetrexed + LY2603618
Dalantercept + Cisplatin
Nivolumab + Cisplatin + Fluorouacil
ACY-1215 + Cisplatin + Gemcitabine
Cyclophosphamide + Cisplatin + Vincristine
Avelumab + Cisplatin
Bevacizumab + Cisplatin + Paclitaxel + Pembrolizumab
AMG 232 + Cisplatin
Cisplatin + Gemcitabine + LY3039478
AZD6738 + Cisplatin
Cisplatin + Prexasertib
Cetuximab + Cisplatin + Paclitaxel + Radiotherapy
Cisplatin + Palbociclib
Cisplatin + Cytarabine + Dexamethasone
Cisplatin + Gemcitabine + PEGPH20
Cisplatin + PJ34
Ruxolitinib + Cisplatin + Pemetrexed
BGB-A317 + Cisplatin + Fluorouracil Tislelizumab (BGB-A317) is a human monoclonal antibody that targets PD-1 (PDCD1), thereby blocking the binding of PD-L1 (CD274) and potentially resulting in activation of a T-cell immune response against tumor cells (NCI Drug Dictionary).
Carboplatin + Cisplatin + Paclitaxel + Pemetrexed
Cisplatin + Perifosine
Cisplatin + Nivolumab + Pemetrexed
Belinostat + Cisplatin + Etoposide
Cisplatin + Gemcitabine + Silmitasertib
C3742 + Cisplatin
Cisplatin + Durvalumab + Gemcitabine
Cisplatin + Etoposide + Osimertinib
Atezolizumab + Cisplatin + Gemcitabine + PEGPH20
Atezolizumab + Cisplatin + Pemetrexed
Cisplatin + Pemetrexed
BKM120 + Cisplatin
Carboplatin + Cetuximab + Cisplatin + Fluorouracil
ABT-737 + Cisplatin
Capecitabine + Cisplatin + Pembrolizumab
ER2 + Cisplatin
Capecitabine + Cisplatin + Trastuzumab
BKM120 + Gemcitabine + Cisplatin
Aldoxorubicin + Cisplatin + Cyclophosphamide + Dexamethasone + Etoposide
Cetuximab + ECF
Cisplatin + Doxorubicin + Cyclophosphamide
Cisplatin + Gemcitabine + Nivolumab
AZD9150 + Cisplatin + Durvalumab + Fluorouracil
Cediranib + Gemcitabine + Cisplatin
Cisplatin + Pembrolizumab + Pemetrexed
Necitumumab + Gemcitabine + Cisplatin
Ficlatuzumab + Cisplatin
Cisplatin + Fluorouracil + Pembrolizumab
Cisplatin + Selinexor
MEK162 + Gemcitabine + Cisplatin
Cisplatin + Romidepsin
Aldoxorubicin + Cisplatin + Filgrastim + Methotrexate + Vinblastine
Cisplatin + Pembrolizumab
Cisplatin + Pictilisib
Cisplatin + Paclitaxel + Pembrolizumab
Cetuximab + IC
Cisplatin + Doxorubicin + Sorafenib
Avelumab + Cisplatin + Fluorouracil + Mitomycin C
Pemetrexed + PDR001 + Cisplatin + Carboplatin
Cetuximab + Cisplatin + Fluorouracil + Radiotherapy
Cisplatin + Etoposide + Ipilimumab
Abraxane + Cisplatin + Carboplatin
Cisplatin + Metformin
Capecitabine + Cisplatin + Pembrolizumab + Trastuzumab
Atezolizumab + Cisplatin
Abraxane + Cisplatin + Cetuximab
Cisplatin + Gemcitabine + nab-paclitaxel + Nivolumab + Paricalcitol
AZD9150 + Cisplatin + Durvalumab + Gemcitabine
Cetuximab + Cisplatin + Paclitaxel
Cisplatin + Etoposide + Paclitaxel + Carboplatin + Erlotinib
MEDI4736 + Tremelimumab + Carboplatin + Cisplatin + Etoposide
Nutlin-3 + Cisplatin
Erlotinib + Cisplatin
Cisplatin + KPT-185
Cisplatin + Gemcitabine + INCB001158
Cetuximab + Cisplatin
Deguelin + Cisplatin
Carboplatin + Cisplatin + Pembrolizumab + Pemetrexed
Sapitinib + Fluorouracil + Cisplatin
Cisplatin + Gemcitabine + PDR001
Carboplatin + Cisplatin + Durvalumab + Paclitaxel
Cisplatin + Gemcitabine + Sirolimus
Cisplatin + Docetaxel + Nintedanib
Alisertib + Cisplatin
Atezolizumab + Cisplatin + Gemcitabine
Carboplatin + Cisplatin + Durvalumab + Etoposide
Cisplatin + Fluorouracil
Capcitabine + Cisplatin + Pertuzumab + Trastuzumab
Cisplatin + Ipilimumab + Pemetrexed
Cisplatin + Docetaxel + Fluorouracil
Cisplatin + Pemetrexed + PDR001
Cisplatin + Trabectedin
BGB-324 + Cisplatin + Gemcitabine + Nab-paclitaxel BGB-324 (Bemcentinib) is a small molecule inhibitor of Axl, which inhibits tumor growth and may overcome EMT-mediated acquired drug resistance (PMID: 20145120).
Adavosertib + Cisplatin + Docetaxel
Cisplatin + Lestaurtinib
BKM120 + Etoposide + Cisplatin
PEXG
Atezolizumab + Carboplatin + Cisplatin + nab-paclitaxel + Pemetrexed
Cisplatin + Etoposide + Roniciclib
Bevacizumab + Cisplatin + Paclitaxel
Cisplatin + Veliparib + VX-970